NXGL Total Utang marang Modal NEXGEL

NXGL (NEXGEL, Inc.) - tandha merek perusahaan

This daily price chart for NEXGEL, Inc. (NXGL) illustrates a debt-to-equity ratio of 1.63. NEXGEL, Inc. (NXGL) leverages glue-free hydrogel crosslinking, which ensures stable demand and pricing power. The business operates as a B2B contract manufacturing platform, where the deep integration of formulas into partner products guarantees customer loyalty. Success is driven by a staff of innovative polymer experts and low employee turnover.

Rasio Utang marang Ekuitas: nexgel.com (NXGL) kanggo 04.07.2022 - 29.10.2026

Rincian analitis lan laporan data perusahaan NEXGEL Inc (NXGL)

- rega lan prakiraan konsensus rega:
Bagan rega NEXGEL|NXGL - Target konsensus
- data kapitalisasi pasar:
Kapitalisasi pasar NEXGEL|NXGL - Total Nilai Perusahaan
- data kapitalisasi buku:
Nilai Buku saben Saham NEXGEL|NXGL - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku nexgel.com|NXGL - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal NEXGEL, Inc.|NXGL - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal NEXGEL, Inc.|NXGL - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku NEXGEL|NXGL - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan NEXGEL
Ringkesan analisis perusahaan:NXGL, NEXGEL
Produk merek NEXGEL Inc

This metric reflects the proportion of borrowed funds to equity, determining the degree of financial leverage and the extent to which business development depends on external lending. A stable flow of free cash flow from NEXGEL, Inc. (NXGL) long-term contracts for the supply of hydrogel dressings minimizes over-leverage risks, allowing for an assessment of the overall stability of the balance sheet structure via the debt-to-equity ratio.

Analisis perusahaan pesaing

Utang marang Ekuitas ISRG|Rasio Total Utang marang Ekuitas Danaher Corporation|Becton, Dickinson and Company - Total Utang marang Modal|Utang marang Modal STERIS Group (STE)|WST - Total Utang marang Modal|Rasio Utang marang Ekuitas baxter.com BAX|Total Utang marang Modal MASI (Masimo)|STVN - Koefisien Total Utang marang Modal|TFX (Teleflex Inc) - Total Utang marang Modal|Merit Medical Corp (MMSI) - Rasio Total Utang marang Ekuitas|NVST (Envista Holdings) - Total Utang marang Modal|Total Utang marang Modal ICUI|Utang marang Ekuitas Dentsply Sirona (XRAY)|Utang marang Ekuitas LeMaitre Vascular Inc LMAT|Rasio Total Utang marang Ekuitas AtriCure Corp|Rasio Kabeh Utang marang Dana Pribadi STAAR Surgical Co STAA|Total Utang marang Modal NAGE (ChromaDex Corp.)|ZIMV: Koefisien Total Utang marang Modal|Utang marang Ekuitas AngioDynamics|CERS (Cerus Corp.) - Rasio Utang marang Ekuitas|TKNO: Utang marang Ekuitas|Koefisien Total Utang marang Modal Monogram Orthopedics Inc. (MGRM)|Rasio Total Utang marang Ekuitas Sharps Technology, Inc.|Utang Agregat marang Modal INFU (infusystem.com)|Utang marang Ekuitas Utah Medical Products, Inc.|KRMD - Rasio Kabeh Utang marang Dana Pribadi|Nyxoah, S.A. - Rasio Total Utang marang Ekuitas|MBOT: Total Utang marang Modal|PDEX (Pro-Dex, Inc.) - Utang marang Ekuitas|zentek.com (ZTEK) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ELUT (Elutia)|Utang marang Modal MLSS|Utang marang Ekuitas Retractable Technologies RVP|Rasio Utang marang Ekuitas harvardbioscience.com HBIO|Rasio Total Utang marang Ekuitas Femasys Inc. (FEMY)|Meihua Medical Technologies - Utang Agregat marang Modal|Utang marang Ekuitas POAI (Predictive Oncology Corp)|CJMB: Koefisien Total Utang marang Modal|Utang marang Ekuitas Atrion Corp|NeuroMetrix Corporation (NURO) - Rasio Utang marang Ekuitas